Show simple item record

dc.contributor.authorUrbanek, M
dc.contributor.authorHayes, MG
dc.contributor.authorLee, H
dc.contributor.authorFreathy, RM
dc.contributor.authorLowe, LP
dc.contributor.authorAckerman, C
dc.contributor.authorJafari, N
dc.contributor.authorDyer, AR
dc.contributor.authorCox, NJ
dc.contributor.authorDunger, DB
dc.contributor.authorHattersley, AT
dc.contributor.authorMetzger, BE
dc.contributor.authorLowe, WL
dc.date.accessioned2017-02-27T13:49:14Z
dc.date.issued2012
dc.description.abstractBACKGROUND: Since mediators of inflammation are associated with insulin resistance, and the risk of developing diabetes mellitus and gestational diabetes, we hypothesized that genetic variation in members of the inflammatory gene pathway impact glucose levels and related phenotypes in pregnancy. We evaluated this hypothesis by testing for association between genetic variants in 31 inflammatory pathway genes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort, a large multiethnic multicenter study designed to address the impact of glycemia less than overt diabetes on pregnancy outcome. RESULTS: Fasting, 1-hour, and 2-hour glucose, fasting and 1-hour C-peptide, and HbA1c levels were measured in blood samples obtained from HAPO participants during an oral glucose tolerance test at 24-32 weeks gestation. We tested for association between 458 SNPs mapping to 31 genes in the inflammatory pathway and metabolic phenotypes in 3836 European ancestry and 1713 Thai pregnant women. The strongest evidence for association was observed with TNF alpha and HbA1c (rs1052248; 0.04% increase per allele C; p-value = 4.4×10(-5)), RETN and fasting plasma glucose (rs1423096; 0.7 mg/dl decrease per allele A; p-value = 1.1×10(-4)), IL8 and 1 hr plasma glucose (rs2886920; 2.6 mg/dl decrease per allele T; p-value = 1.3×10(-4)), ADIPOR2 and fasting C-peptide (rs2041139; 0.55 ug/L decrease per allele A; p-value = 1.4×10(-4)), LEPR and 1-hour C-peptide (rs1171278; 0.62 ug/L decrease per allele T; p-value = 2.4×10(-4)), and IL6 and 1-hour plasma glucose (rs6954897; -2.29 mg/dl decrease per allele G, p-value = 4.3×10(-4)). CONCLUSIONS: Based on the genes surveyed in this study the inflammatory pathway is unlikely to have a strong impact on maternal metabolic phenotypes in pregnancy although variation in individual members of the pathway (e.g. RETN, IL8, ADIPOR2, LEPR, IL6, and TNF alpha,) may contribute to metabolic phenotypes in pregnant women.en_GB
dc.description.sponsorshipThe study is funded by grants R01 DK067459, R01-HD34242 and R01-HD34243 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases, by the National Center for Research Resources (M01-RR00048, M01- RR00080), and by the American Diabetes Association. RMF is funded by a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust grant: 085541/Z/08/Z). ATH is employed as a core member of the Peninsula NIHR Clinical Research Facility. Support has also been provided to local field centers by Diabetes UK (RD04/ 0002756), Kaiser Permanente Medical Center, KK Women’s and Children’s Hospital, Mater Mother’s Hospital, Novo Nordisk, the Myre Sim Fund of the Royal College of Physicians of Edinburgh, and the Howard and Carol Bernick Family Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.en_GB
dc.identifier.citationVol. 7, e32958en_GB
dc.identifier.doi10.1371/journal.pone.0032958
dc.identifier.otherPONE-D-11-09332
dc.identifier.urihttp://hdl.handle.net/10871/26080
dc.language.isoenen_GB
dc.publisherPublic Library of Scienceen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/22479352en_GB
dc.rights© 2012 Urbanek et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_GB
dc.subjectAsian Continental Ancestry Groupen_GB
dc.subjectBlood Glucoseen_GB
dc.subjectC-Peptideen_GB
dc.subjectCohort Studiesen_GB
dc.subjectEuropean Continental Ancestry Groupen_GB
dc.subjectFastingen_GB
dc.subjectFemaleen_GB
dc.subjectGenetic Predisposition to Diseaseen_GB
dc.subjectGlucose Tolerance Testen_GB
dc.subjectHemoglobin A, Glycosylateden_GB
dc.subjectHumansen_GB
dc.subjectHyperglycemiaen_GB
dc.subjectInflammationen_GB
dc.subjectInterleukin-6en_GB
dc.subjectInterleukin-8en_GB
dc.subjectPolymorphism, Single Nucleotideen_GB
dc.subjectPregnancyen_GB
dc.subjectPregnancy Complicationsen_GB
dc.subjectPregnancy Outcomeen_GB
dc.subjectReceptors, Adiponectinen_GB
dc.subjectReceptors, Leptinen_GB
dc.subjectResistinen_GB
dc.subjectSignal Transductionen_GB
dc.subjectThailanden_GB
dc.subjectTumor Necrosis Factor-alphaen_GB
dc.titleThe role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancyen_GB
dc.typeArticleen_GB
dc.date.available2017-02-27T13:49:14Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version of the article. Available from the publisher via the DOI in this record.en_GB
dc.identifier.journalPLoS Oneen_GB
dc.identifier.pmcidPMC3316547
dc.identifier.pmid22479352


Files in this item

This item appears in the following Collection(s)

Show simple item record